The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for H Ju


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives.EBI
Shandong University
Development of chalcone-like derivatives and their biological and mechanistic investigations as novel influenza nuclear export inhibitors.EBI
Shandong University
Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities.EBI
Shandong University
Identification of C5-NHEBI
Shandong University
Iterative Optimization and Structure-Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors EBI
Shandong University
Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.EBI
Tianjin University of Traditional Chinese Medicine
Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy.EBI
Tianjin University of Traditional Chinese Medicine
Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity.EBI
Shandong University
Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant.EBI
Shandong University
Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors.EBI
Shandong University